| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of skin epidermis | 3.67e-12 | 43 | 21 | 6 | GO:0030280 | |
| GeneOntologyMolecularFunction | structural molecule activity | 1.22e-07 | 891 | 21 | 9 | GO:0005198 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 2.03e-07 | 130 | 21 | 5 | GO:0005200 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 2.51e-03 | 560 | 21 | 4 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 2.60e-03 | 566 | 21 | 4 | GO:0001216 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 4.25e-03 | 93 | 21 | 2 | GO:0097110 | |
| GeneOntologyBiologicalProcess | intermediate filament organization | 4.08e-15 | 75 | 21 | 8 | GO:0045109 | |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | 4.08e-14 | 99 | 21 | 8 | GO:0045104 | |
| GeneOntologyBiologicalProcess | intermediate filament-based process | 4.43e-14 | 100 | 21 | 8 | GO:0045103 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | SIX3 KRT1 KRT2 KRT3 KRT5 LORICRIN KRT9 KRT10 KRT13 KRT15 MAF | 1.69e-10 | 870 | 21 | 11 | GO:0030855 |
| GeneOntologyBiologicalProcess | epithelium development | SIX3 KRT1 KRT2 KRT3 KRT5 LORICRIN KRT9 KRT10 KRT13 FOXD1 KRT15 MAF | 2.62e-09 | 1469 | 21 | 12 | GO:0060429 |
| GeneOntologyBiologicalProcess | epidermis development | 9.24e-09 | 461 | 21 | 8 | GO:0008544 | |
| GeneOntologyBiologicalProcess | peptide cross-linking | 1.37e-08 | 27 | 21 | 4 | GO:0018149 | |
| GeneOntologyBiologicalProcess | keratinization | 2.29e-08 | 87 | 21 | 5 | GO:0031424 | |
| GeneOntologyBiologicalProcess | keratinocyte differentiation | 2.65e-08 | 189 | 21 | 6 | GO:0030216 | |
| GeneOntologyBiologicalProcess | skin development | 5.59e-08 | 373 | 21 | 7 | GO:0043588 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | 1.70e-07 | 957 | 21 | 9 | GO:0097435 | |
| GeneOntologyBiologicalProcess | epidermal cell differentiation | 2.95e-07 | 284 | 21 | 6 | GO:0009913 | |
| GeneOntologyBiologicalProcess | protein heterotetramerization | 1.17e-04 | 16 | 21 | 2 | GO:0051290 | |
| GeneOntologyBiologicalProcess | keratinocyte development | 1.33e-04 | 17 | 21 | 2 | GO:0003334 | |
| GeneOntologyBiologicalProcess | protein heterooligomerization | 4.51e-04 | 31 | 21 | 2 | GO:0051291 | |
| GeneOntologyBiologicalProcess | positive regulation of epidermis development | 5.11e-04 | 33 | 21 | 2 | GO:0045684 | |
| GeneOntologyBiologicalProcess | rRNA modification | 6.09e-04 | 36 | 21 | 2 | GO:0000154 | |
| GeneOntologyBiologicalProcess | proximal/distal pattern formation | 6.44e-04 | 37 | 21 | 2 | GO:0009954 | |
| GeneOntologyBiologicalProcess | cellular response to angiotensin | 7.52e-04 | 40 | 21 | 2 | GO:1904385 | |
| GeneOntologyBiologicalProcess | lens fiber cell differentiation | 9.10e-04 | 44 | 21 | 2 | GO:0070306 | |
| GeneOntologyBiologicalProcess | response to angiotensin | 1.17e-03 | 50 | 21 | 2 | GO:1990776 | |
| GeneOntologyBiologicalProcess | response to mechanical stimulus | 1.92e-03 | 247 | 21 | 3 | GO:0009612 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | 2.16e-03 | 1399 | 21 | 6 | GO:0045892 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | 2.27e-03 | 1413 | 21 | 6 | GO:1902679 | |
| GeneOntologyBiologicalProcess | regulation of epidermis development | 2.35e-03 | 71 | 21 | 2 | GO:0045682 | |
| GeneOntologyBiologicalProcess | epithelial cell development | 2.45e-03 | 269 | 21 | 3 | GO:0002064 | |
| GeneOntologyCellularComponent | keratin filament | 4.10e-12 | 97 | 21 | 7 | GO:0045095 | |
| GeneOntologyCellularComponent | intermediate filament | 3.08e-11 | 227 | 21 | 8 | GO:0005882 | |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | 9.97e-11 | 263 | 21 | 8 | GO:0045111 | |
| GeneOntologyCellularComponent | cornified envelope | 6.60e-09 | 69 | 21 | 5 | GO:0001533 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | 8.91e-08 | 899 | 21 | 9 | GO:0099513 | |
| GeneOntologyCellularComponent | supramolecular fiber | 8.88e-07 | 1179 | 21 | 9 | GO:0099512 | |
| GeneOntologyCellularComponent | supramolecular polymer | 9.40e-07 | 1187 | 21 | 9 | GO:0099081 | |
| GeneOntologyCellularComponent | dense fibrillar component | 2.01e-05 | 7 | 21 | 2 | GO:0001651 | |
| GeneOntologyCellularComponent | chromatin | 4.22e-04 | 1480 | 21 | 7 | GO:0000785 | |
| GeneOntologyCellularComponent | sno(s)RNA-containing ribonucleoprotein complex | 4.68e-04 | 32 | 21 | 2 | GO:0005732 | |
| GeneOntologyCellularComponent | Cajal body | 3.19e-03 | 84 | 21 | 2 | GO:0015030 | |
| HumanPheno | Congenital bullous ichthyosiform erythroderma | 6.60e-08 | 4 | 14 | 3 | HP:0007475 | |
| HumanPheno | Abnormal epidermal morphology | 8.97e-08 | 94 | 14 | 6 | HP:0011124 | |
| HumanPheno | Epidermal acanthosis | 2.06e-07 | 54 | 14 | 5 | HP:0025092 | |
| HumanPheno | Hypergranulosis | 2.54e-07 | 22 | 14 | 4 | HP:0025114 | |
| HumanPheno | Palmoplantar hyperkeratosis | 5.97e-07 | 129 | 14 | 6 | HP:0000972 | |
| HumanPheno | Palmar hyperkeratosis | 6.54e-07 | 131 | 14 | 6 | HP:0010765 | |
| HumanPheno | Plantar hyperkeratosis | 6.85e-07 | 132 | 14 | 6 | HP:0007556 | |
| HumanPheno | Knuckle pad | 9.18e-07 | 8 | 14 | 3 | HP:0032541 | |
| HumanPheno | Hyperkeratosis | 9.99e-07 | 233 | 14 | 7 | HP:0000962 | |
| HumanPheno | Abnormality of keratinization | 1.37e-06 | 244 | 14 | 7 | HP:0001035 | |
| HumanPheno | Parakeratosis | 1.40e-06 | 33 | 14 | 4 | HP:0001036 | |
| HumanPheno | Congenital ichthyosiform erythroderma | 1.40e-06 | 33 | 14 | 4 | HP:0007431 | |
| HumanPheno | Abnormality of the plantar skin of foot | 3.15e-06 | 171 | 14 | 6 | HP:0100872 | |
| HumanPheno | Palmoplantar keratoderma | 8.76e-06 | 114 | 14 | 5 | HP:0000982 | |
| HumanPheno | Abnormal blistering of the skin | 9.15e-06 | 115 | 14 | 5 | HP:0008066 | |
| HumanPheno | Orthokeratosis | 1.83e-05 | 20 | 14 | 3 | HP:0040162 | |
| HumanPheno | Erythema | 1.86e-05 | 133 | 14 | 5 | HP:0010783 | |
| HumanPheno | Epidermal thickening | 2.59e-05 | 379 | 14 | 7 | HP:0011368 | |
| HumanPheno | Hyperparakeratosis | 4.20e-05 | 4 | 14 | 2 | HP:0040009 | |
| HumanPheno | Abnormal skin morphology of the palm | 4.55e-05 | 413 | 14 | 7 | HP:0040211 | |
| HumanPheno | Vascular skin abnormality | 5.10e-05 | 593 | 14 | 8 | HP:0011276 | |
| HumanPheno | Skin erosion | 5.20e-05 | 28 | 14 | 3 | HP:0200041 | |
| HumanPheno | Thickened skin | 6.01e-05 | 431 | 14 | 7 | HP:0001072 | |
| HumanPheno | Abnormal nail morphology | 1.91e-04 | 516 | 14 | 7 | HP:0001597 | |
| HumanPheno | Abnormal palm morphology | 2.03e-04 | 521 | 14 | 7 | HP:0100871 | |
| HumanPheno | Scaling skin | 2.34e-04 | 46 | 14 | 3 | HP:0040189 | |
| HumanPheno | Skin plaque | 2.50e-04 | 47 | 14 | 3 | HP:0200035 | |
| HumanPheno | Regional abnormality of skin | 2.58e-04 | 541 | 14 | 7 | HP:0011356 | |
| HumanPheno | Skin ulcer | 3.73e-04 | 134 | 14 | 4 | HP:0200042 | |
| HumanPheno | Conjunctival nodule | 3.80e-04 | 11 | 14 | 2 | HP:0009903 | |
| HumanPheno | Conjunctival hamartoma | 3.80e-04 | 11 | 14 | 2 | HP:0100780 | |
| HumanPheno | Epidermal hyperkeratosis | 3.80e-04 | 11 | 14 | 2 | HP:0007543 | |
| HumanPheno | Palmoplantar blistering | 3.80e-04 | 11 | 14 | 2 | HP:0007446 | |
| HumanPheno | Diffuse palmoplantar hyperkeratosis | 3.80e-04 | 11 | 14 | 2 | HP:0007447 | |
| HumanPheno | Amniotic constriction ring | 3.80e-04 | 11 | 14 | 2 | HP:0009775 | |
| HumanPheno | Ichthyosis | 4.92e-04 | 144 | 14 | 4 | HP:0008064 | |
| HumanPheno | Hyperkeratotic papule | 5.38e-04 | 13 | 14 | 2 | HP:0045059 | |
| HumanPheno | Abnormal placental membrane morphology | 6.26e-04 | 14 | 14 | 2 | HP:0011409 | |
| HumanPheno | Nail dystrophy | 6.66e-04 | 156 | 14 | 4 | HP:0008404 | |
| HumanPheno | Localized skin lesion | 9.88e-04 | 897 | 14 | 8 | HP:0011355 | |
| HumanPheno | Hypoplastic fifth toenail | 1.17e-03 | 19 | 14 | 2 | HP:0011937 | |
| MousePheno | acanthosis | 3.63e-07 | 43 | 20 | 4 | MP:0001874 | |
| MousePheno | epidermis stratum spinosum hyperplasia | 4.37e-07 | 45 | 20 | 4 | MP:0009611 | |
| MousePheno | abnormal epidermis stratum corneum morphology | 9.63e-07 | 132 | 20 | 5 | MP:0001240 | |
| MousePheno | abnormal epidermal layer morphology | 1.55e-06 | 271 | 20 | 6 | MP:0001216 | |
| MousePheno | abnormal esophageal epithelium morphology | 1.68e-06 | 17 | 20 | 3 | MP:0000468 | |
| MousePheno | abnormal epidermis stratum spinosum morphology | 1.95e-06 | 65 | 20 | 4 | MP:0001236 | |
| MousePheno | blistering | 4.97e-06 | 24 | 20 | 3 | MP:0001208 | |
| MousePheno | abnormal foot pad morphology | 6.38e-06 | 26 | 20 | 3 | MP:0000574 | |
| MousePheno | hyperkeratosis | 7.19e-06 | 90 | 20 | 4 | MP:0001242 | |
| MousePheno | hyperpigmentation | 8.02e-06 | 28 | 20 | 3 | MP:0001188 | |
| MousePheno | abnormal skin physiology | 4.31e-05 | 288 | 20 | 5 | MP:0005501 | |
| MousePheno | abnormal Peyer's patch T cell area morphology | 5.42e-05 | 8 | 20 | 2 | MP:0002392 | |
| MousePheno | scaly skin | 6.27e-05 | 55 | 20 | 3 | MP:0001192 | |
| MousePheno | hypergranulosis | 6.96e-05 | 9 | 20 | 2 | MP:0009600 | |
| MousePheno | perinatal lethality | 9.27e-05 | 1130 | 20 | 8 | MP:0002081 | |
| MousePheno | impaired skin barrier function | 9.87e-05 | 64 | 20 | 3 | MP:0002796 | |
| MousePheno | abnormal esophagus morphology | 1.08e-04 | 66 | 20 | 3 | MP:0000467 | |
| MousePheno | thick epidermis stratum granulosum | 1.27e-04 | 12 | 20 | 2 | MP:0009599 | |
| MousePheno | abnormal epidermis stratum granulosum morphology | 1.29e-04 | 70 | 20 | 3 | MP:0001239 | |
| MousePheno | translucent skin | 2.02e-04 | 15 | 20 | 2 | MP:0001201 | |
| MousePheno | abnormal epidermis suprabasal layer morphology | 2.02e-04 | 15 | 20 | 2 | MP:0001233 | |
| MousePheno | abnormal corneocyte morphology | 2.93e-04 | 18 | 20 | 2 | MP:0030605 | |
| MousePheno | perinatal lethality, complete penetrance | 3.58e-04 | 712 | 20 | 6 | MP:0011089 | |
| MousePheno | abnormal skin appearance | 4.42e-04 | 473 | 20 | 5 | MP:0009931 | |
| MousePheno | decreased skin tensile strength | 6.19e-04 | 26 | 20 | 2 | MP:0003089 | |
| MousePheno | neonatal lethality | 6.64e-04 | 799 | 20 | 6 | MP:0002058 | |
| MousePheno | increased keratinocyte proliferation | 6.68e-04 | 27 | 20 | 2 | MP:0009583 | |
| MousePheno | abnormal tongue epithelium morphology | 6.68e-04 | 27 | 20 | 2 | MP:0000764 | |
| MousePheno | abnormal Peyer's patch follicle morphology | 7.71e-04 | 29 | 20 | 2 | MP:0002389 | |
| MousePheno | abnormal skin tensile strength | 9.40e-04 | 32 | 20 | 2 | MP:0005275 | |
| MousePheno | decreased circulating sodium level | 1.19e-03 | 36 | 20 | 2 | MP:0005634 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | 1.34e-03 | 1269 | 20 | 7 | MP:0011111 | |
| MousePheno | abnormal keratinocyte proliferation | 1.54e-03 | 41 | 20 | 2 | MP:0009582 | |
| MousePheno | abnormal autopod morphology | 2.03e-03 | 390 | 20 | 4 | MP:0000572 | |
| MousePheno | craniofacial phenotype | 2.12e-03 | 1372 | 20 | 7 | MP:0005382 | |
| MousePheno | abnormal craniofacial morphology | 2.12e-03 | 1372 | 20 | 7 | MP:0000428 | |
| MousePheno | increased cell proliferation | 2.14e-03 | 396 | 20 | 4 | MP:0000351 | |
| MousePheno | abnormal response to social novelty | 2.20e-03 | 49 | 20 | 2 | MP:0020395 | |
| MousePheno | abnormal tail morphology | 2.29e-03 | 403 | 20 | 4 | MP:0002111 | |
| Domain | Intermediate_filament_CS | 2.08e-15 | 63 | 21 | 8 | IPR018039 | |
| Domain | Filament | 5.68e-15 | 71 | 21 | 8 | SM01391 | |
| Domain | IF | 6.38e-15 | 72 | 21 | 8 | PS00226 | |
| Domain | Filament | 7.17e-15 | 73 | 21 | 8 | PF00038 | |
| Domain | IF | 1.00e-14 | 76 | 21 | 8 | IPR001664 | |
| Domain | Keratin_I | 6.33e-12 | 44 | 21 | 6 | IPR002957 | |
| Domain | Keratin_2_head | 1.24e-08 | 24 | 21 | 4 | IPR032444 | |
| Domain | Keratin_2_head | 1.24e-08 | 24 | 21 | 4 | PF16208 | |
| Domain | Keratin_II | 1.74e-08 | 26 | 21 | 4 | IPR003054 | |
| Domain | Prefoldin | 6.95e-05 | 72 | 21 | 3 | IPR009053 | |
| Domain | HTH_motif | 2.70e-03 | 69 | 21 | 2 | IPR000047 | |
| Domain | Homeobox | 2.81e-02 | 234 | 21 | 2 | PF00046 | |
| Domain | HOMEOBOX_1 | 2.85e-02 | 236 | 21 | 2 | PS00027 | |
| Domain | HOX | 2.87e-02 | 237 | 21 | 2 | SM00389 | |
| Domain | Homeobox_dom | 2.92e-02 | 239 | 21 | 2 | IPR001356 | |
| Domain | HOMEOBOX_2 | 2.92e-02 | 239 | 21 | 2 | PS50071 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 5.23e-14 | 129 | 20 | 9 | M27649 | |
| Pathway | REACTOME_KERATINIZATION | 5.96e-12 | 217 | 20 | 9 | M27640 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 1.94e-11 | 87 | 20 | 7 | MM15351 | |
| Pathway | REACTOME_KERATINIZATION | 1.06e-09 | 153 | 20 | 7 | MM15343 | |
| Pathway | REACTOME_DIFFERENTIATION_OF_KERATINOCYTES_IN_INTERFOLLICULAR_EPIDERMIS_IN_MAMMALIAN_SKIN | 2.13e-09 | 40 | 20 | 5 | M48231 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | KRT1 KRT2 KRT3 KCNQ3 KRT5 LORICRIN KRT9 KRT10 CACNG8 KRT13 ARID1B NFKB1 KRT15 | 4.56e-09 | 1432 | 20 | 13 | M509 |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 2.11e-07 | 502 | 20 | 8 | MM14537 | |
| Pathway | WP_ULCERATIVE_COLITIS_SIGNALING | 2.89e-04 | 18 | 20 | 2 | M45536 | |
| Pubmed | 6.24e-18 | 57 | 21 | 8 | 31862882 | ||
| Pubmed | 1.46e-17 | 63 | 21 | 8 | 16831889 | ||
| Pubmed | 2.95e-15 | 24 | 21 | 6 | 27507811 | ||
| Pubmed | 3.61e-15 | 60 | 21 | 7 | 31220272 | ||
| Pubmed | 6.50e-15 | 65 | 21 | 7 | 29795372 | ||
| Pubmed | Reactive-site-centric chemoproteomics identifies a distinct class of deubiquitinase enzymes. | 4.20e-14 | 84 | 21 | 7 | 29563501 | |
| Pubmed | 6.16e-14 | 13 | 21 | 5 | 8999895 | ||
| Pubmed | Multiple roles of Notch signaling in the regulation of epidermal development. | 1.44e-13 | 15 | 21 | 5 | 18410734 | |
| Pubmed | 2.67e-13 | 48 | 21 | 6 | 35247391 | ||
| Pubmed | GAR1 KRT1 KRT2 KRT3 FBL KRT5 KRT9 KRT10 KRT13 ARID1B HNRNPL KRT15 | 3.72e-13 | 1153 | 21 | 12 | 29845934 | |
| Pubmed | 4.09e-13 | 18 | 21 | 5 | 20335364 | ||
| Pubmed | 1.47e-12 | 6 | 21 | 4 | 7525178 | ||
| Pubmed | Loss of proteolytically processed filaggrin caused by epidermal deletion of Matriptase/MT-SP1. | 1.47e-12 | 6 | 21 | 4 | 14638864 | |
| Pubmed | 1.97e-12 | 266 | 21 | 8 | 19380743 | ||
| Pubmed | 2.03e-12 | 24 | 21 | 5 | 30719818 | ||
| Pubmed | Regulation of epidermal differentiation by a Distal-less homeodomain gene. | 3.43e-12 | 7 | 21 | 4 | 8991098 | |
| Pubmed | mTORC1 and mTORC2 regulate skin morphogenesis and epidermal barrier formation. | 3.84e-12 | 27 | 21 | 5 | 27807348 | |
| Pubmed | The cellular EJC interactome reveals higher-order mRNP structure and an EJC-SR protein nexus. | 6.20e-12 | 169 | 21 | 7 | 23084401 | |
| Pubmed | 6.86e-12 | 8 | 21 | 4 | 7543090 | ||
| Pubmed | Aurora kinase-A deficiency during skin development impairs cell division and stratification. | 1.23e-11 | 9 | 21 | 4 | 22832491 | |
| Pubmed | TRIM25 and DEAD-Box RNA Helicase DDX3X Cooperate to Regulate RIG-I-Mediated Antiviral Immunity. | 1.43e-11 | 91 | 21 | 6 | 34445801 | |
| Pubmed | 1.61e-11 | 346 | 21 | 8 | 25324306 | ||
| Pubmed | 2.06e-11 | 10 | 21 | 4 | 24940650 | ||
| Pubmed | Spatiotemporal expression pattern of keratins in skin of AP-2alpha-deficient mice. | 2.06e-11 | 10 | 21 | 4 | 10571739 | |
| Pubmed | 3.23e-11 | 11 | 21 | 4 | 22366455 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 3.33e-11 | 1257 | 21 | 11 | 36526897 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 3.36e-11 | 605 | 21 | 9 | 28977666 | |
| Pubmed | A functional reference map of the RNF8 interactome in cancer. | 3.73e-11 | 218 | 21 | 7 | 35831895 | |
| Pubmed | 6.48e-11 | 46 | 21 | 5 | 36147463 | ||
| Pubmed | DDX24 promotes metastasis by regulating RPL5 in non-small cell lung cancer. | 6.89e-11 | 238 | 21 | 7 | 35864588 | |
| Pubmed | Fate and plasticity of the epidermis in response to congenital activation of BRAF. | 7.00e-11 | 13 | 21 | 4 | 25202828 | |
| Pubmed | Mice with a targeted mutation of patched2 are viable but develop alopecia and epidermal hyperplasia. | 9.79e-11 | 14 | 21 | 4 | 16914743 | |
| Pubmed | Desmosomal localization of beta-catenin in the skin of plakoglobin null-mutant mice. | 1.33e-10 | 15 | 21 | 4 | 9847250 | |
| Pubmed | 1.49e-10 | 54 | 21 | 5 | 35474131 | ||
| Pubmed | E3 Ligase Trim21 Ubiquitylates and Stabilizes Keratin 17 to Induce STAT3 Activation in Psoriasis. | 1.58e-10 | 135 | 21 | 6 | 29859926 | |
| Pubmed | 1.78e-10 | 16 | 21 | 4 | 17631878 | ||
| Pubmed | 1.90e-10 | 3 | 21 | 3 | 26581228 | ||
| Pubmed | 2.49e-10 | 286 | 21 | 7 | 32041737 | ||
| Pubmed | 2.99e-10 | 18 | 21 | 4 | 24982158 | ||
| Pubmed | 2.99e-10 | 18 | 21 | 4 | 24735878 | ||
| Pubmed | Ezh2 orchestrates gene expression for the stepwise differentiation of tissue-specific stem cells. | 2.99e-10 | 18 | 21 | 4 | 19303854 | |
| Pubmed | Patched 1 and patched 2 redundancy has a key role in regulating epidermal differentiation. | 3.78e-10 | 19 | 21 | 4 | 24492243 | |
| Pubmed | 3.78e-10 | 19 | 21 | 4 | 35173535 | ||
| Pubmed | Canonical notch signaling functions as a commitment switch in the epidermal lineage. | 5.84e-10 | 21 | 21 | 4 | 17079689 | |
| Pubmed | EEF1D Promotes Glioma Proliferation, Migration, and Invasion through EMT and PI3K/Akt Pathway. | 5.84e-10 | 21 | 21 | 4 | 33029523 | |
| Pubmed | HDM2-binding partners: interaction with translation elongation factor EF1alpha. | 5.84e-10 | 21 | 21 | 4 | 17373842 | |
| Pubmed | 6.74e-10 | 330 | 21 | 7 | 32529326 | ||
| Pubmed | 7.13e-10 | 22 | 21 | 4 | 17276340 | ||
| Pubmed | 7.13e-10 | 22 | 21 | 4 | 19749746 | ||
| Pubmed | BMP-FGF signaling axis mediates Wnt-induced epidermal stratification in developing mammalian skin. | 7.13e-10 | 22 | 21 | 4 | 25329657 | |
| Pubmed | 7.59e-10 | 4 | 21 | 3 | 7679677 | ||
| Pubmed | 7.59e-10 | 4 | 21 | 3 | 32179842 | ||
| Pubmed | Transcription Factor MafB Coordinates Epidermal Keratinocyte Differentiation. | 1.04e-09 | 24 | 21 | 4 | 27208706 | |
| Pubmed | 1.13e-09 | 187 | 21 | 6 | 29777862 | ||
| Pubmed | 1.23e-09 | 25 | 21 | 4 | 23132931 | ||
| Pubmed | Beclin 1 regulates recycling endosome and is required for skin development in mice. | 1.71e-09 | 27 | 21 | 4 | 30701202 | |
| Pubmed | The RNA-binding protein YBX1 regulates epidermal progenitors at a posttranscriptional level. | 1.90e-09 | 5 | 21 | 3 | 29712925 | |
| Pubmed | 1.90e-09 | 5 | 21 | 3 | 2458356 | ||
| Pubmed | 1.90e-09 | 5 | 21 | 3 | 9665399 | ||
| Pubmed | Sox21 Regulates Anapc10 Expression and Determines the Fate of Ectodermal Organ. | 1.99e-09 | 28 | 21 | 4 | 32674056 | |
| Pubmed | 2.66e-09 | 30 | 21 | 4 | 34905516 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | 2.82e-09 | 1415 | 21 | 10 | 28515276 | |
| Pubmed | 3.06e-09 | 31 | 21 | 4 | 20930145 | ||
| Pubmed | 3.06e-09 | 31 | 21 | 4 | 22274697 | ||
| Pubmed | 3.08e-09 | 221 | 21 | 6 | 31796584 | ||
| Pubmed | 3.41e-09 | 417 | 21 | 7 | 19199708 | ||
| Pubmed | Upregulation of RIN3 induces endosomal dysfunction in Alzheimer's disease. | 3.46e-09 | 418 | 21 | 7 | 32552912 | |
| Pubmed | 3.64e-09 | 421 | 21 | 7 | 34650049 | ||
| Pubmed | Development, structure, and keratin expression in C57BL/6J mouse eccrine glands. | 3.79e-09 | 6 | 21 | 3 | 22135020 | |
| Pubmed | 3.79e-09 | 6 | 21 | 3 | 19300453 | ||
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | 4.21e-09 | 430 | 21 | 7 | 38172120 | |
| Pubmed | 4.52e-09 | 707 | 21 | 8 | 19738201 | ||
| Pubmed | 4.78e-09 | 438 | 21 | 7 | 21630459 | ||
| Pubmed | MicroRNA-203 represses selection and expansion of oncogenic Hras transformed tumor initiating cells. | 6.63e-09 | 7 | 21 | 3 | 26203562 | |
| Pubmed | 6.63e-09 | 7 | 21 | 3 | 10191051 | ||
| Pubmed | Mouse homologue of skin-specific retroviral-like aspartic protease involved in wrinkle formation. | 6.63e-09 | 7 | 21 | 3 | 16837463 | |
| Pubmed | Transcriptional regulation of Oct4 by a long non-coding RNA antisense to Oct4-pseudogene 5. | 8.85e-09 | 40 | 21 | 4 | 21151833 | |
| Pubmed | 9.80e-09 | 41 | 21 | 4 | 34638806 | ||
| Pubmed | Dysregulation of Grainyhead-like 3 expression causes widespread developmental defects. | 1.06e-08 | 8 | 21 | 3 | 36606449 | |
| Pubmed | Calmodulin 4 is dispensable for epidermal barrier formation and wound healing in mice. | 1.06e-08 | 8 | 21 | 3 | 25316000 | |
| Pubmed | Rescue of key features of the p63-null epithelial phenotype by inactivation of Ink4a and Arf. | 1.06e-08 | 8 | 21 | 3 | 19494829 | |
| Pubmed | Essential roles of Tbx3 in embryonic skin development during epidermal stratification. | 1.06e-08 | 8 | 21 | 3 | 28205312 | |
| Pubmed | Induced multipotency in adult keratinocytes through down-regulation of ΔNp63 or DGCR8. | 1.06e-08 | 8 | 21 | 3 | 24449888 | |
| Pubmed | Glucocorticoid receptor antagonizes EGFR function to regulate eyelid development. | 1.06e-08 | 8 | 21 | 3 | 21136383 | |
| Pubmed | 1.44e-08 | 45 | 21 | 4 | 30619335 | ||
| Pubmed | 1.53e-08 | 289 | 21 | 6 | 37132043 | ||
| Pubmed | SOX11 and SOX4 drive the reactivation of an embryonic gene program during murine wound repair. | 1.59e-08 | 9 | 21 | 3 | 31492871 | |
| Pubmed | 1.59e-08 | 9 | 21 | 3 | 22505032 | ||
| Pubmed | 2.10e-08 | 305 | 21 | 6 | 33194618 | ||
| Pubmed | 2.27e-08 | 10 | 21 | 3 | 26376988 | ||
| Pubmed | 2.27e-08 | 10 | 21 | 3 | 39296075 | ||
| Pubmed | Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation. | 2.27e-08 | 10 | 21 | 3 | 14517554 | |
| Pubmed | 2.27e-08 | 10 | 21 | 3 | 24075906 | ||
| Pubmed | Essential role for Sonic hedgehog during hair follicle morphogenesis. | 2.27e-08 | 10 | 21 | 3 | 9882493 | |
| Pubmed | 2.41e-08 | 51 | 21 | 4 | 36896912 | ||
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | 2.52e-08 | 558 | 21 | 7 | 27591049 | |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | 2.71e-08 | 564 | 21 | 7 | 21565611 | |
| Pubmed | 3.12e-08 | 11 | 21 | 3 | 11171335 | ||
| Pubmed | 3.12e-08 | 11 | 21 | 3 | 16085486 | ||
| Pubmed | FGF10 acts as a major ligand for FGF receptor 2 IIIb in mouse multi-organ development. | 3.12e-08 | 11 | 21 | 3 | 11062007 | |
| Interaction | RNF208 interactions | 4.90e-15 | 75 | 21 | 8 | int:RNF208 | |
| Interaction | MINDY4 interactions | 6.80e-13 | 73 | 21 | 7 | int:MINDY4 | |
| Interaction | KRT1 interactions | 6.00e-11 | 238 | 21 | 8 | int:KRT1 | |
| Interaction | KRT7 interactions | 1.67e-10 | 80 | 21 | 6 | int:KRT7 | |
| Interaction | DES interactions | 1.69e-10 | 158 | 21 | 7 | int:DES | |
| Interaction | ZUP1 interactions | 3.33e-10 | 174 | 21 | 7 | int:ZUP1 | |
| Interaction | KRT75 interactions | 4.39e-10 | 181 | 21 | 7 | int:KRT75 | |
| Interaction | INVS interactions | 6.16e-10 | 99 | 21 | 6 | int:INVS | |
| Interaction | KRT5 interactions | 6.88e-10 | 193 | 21 | 7 | int:KRT5 | |
| Interaction | EFNA1 interactions | 7.84e-10 | 103 | 21 | 6 | int:EFNA1 | |
| Interaction | KRT84 interactions | 1.36e-09 | 49 | 21 | 5 | int:KRT84 | |
| Interaction | EPS15 interactions | 1.71e-09 | 220 | 21 | 7 | int:EPS15 | |
| Interaction | CUL5 interactions | 2.25e-09 | 567 | 21 | 9 | int:CUL5 | |
| Interaction | KRT20 interactions | 4.97e-09 | 63 | 21 | 5 | int:KRT20 | |
| Interaction | MAGOH interactions | 6.08e-09 | 264 | 21 | 7 | int:MAGOH | |
| Interaction | HEXIM1 interactions | 7.76e-09 | 913 | 21 | 10 | int:HEXIM1 | |
| Interaction | KRT6A interactions | 1.12e-08 | 160 | 21 | 6 | int:KRT6A | |
| Interaction | CUL4B interactions | 1.98e-08 | 728 | 21 | 9 | int:CUL4B | |
| Interaction | AHI1 interactions | 2.03e-08 | 83 | 21 | 5 | int:AHI1 | |
| Interaction | KRT28 interactions | 2.35e-08 | 30 | 21 | 4 | int:KRT28 | |
| Interaction | FBP1 interactions | 4.07e-08 | 348 | 21 | 7 | int:FBP1 | |
| Interaction | KRT77 interactions | 4.23e-08 | 96 | 21 | 5 | int:KRT77 | |
| Interaction | KRT25 interactions | 4.47e-08 | 35 | 21 | 4 | int:KRT25 | |
| Interaction | COPS5 interactions | 4.66e-08 | 1102 | 21 | 10 | int:COPS5 | |
| Interaction | PRPH interactions | 4.78e-08 | 204 | 21 | 6 | int:PRPH | |
| Interaction | LARP7 interactions | 5.12e-08 | 1113 | 21 | 10 | int:LARP7 | |
| Interaction | SHC1 interactions | 5.33e-08 | 362 | 21 | 7 | int:SHC1 | |
| Interaction | CRK interactions | 6.19e-08 | 370 | 21 | 7 | int:CRK | |
| Interaction | INPPL1 interactions | 6.35e-08 | 214 | 21 | 6 | int:INPPL1 | |
| Interaction | EVPL interactions | 6.97e-08 | 106 | 21 | 5 | int:EVPL | |
| Interaction | EFNA3 interactions | 7.65e-08 | 108 | 21 | 5 | int:EFNA3 | |
| Interaction | NPHP3 interactions | 9.50e-08 | 42 | 21 | 4 | int:NPHP3 | |
| Interaction | PIK3R2 interactions | 9.73e-08 | 230 | 21 | 6 | int:PIK3R2 | |
| Interaction | KRT13 interactions | 1.10e-07 | 116 | 21 | 5 | int:KRT13 | |
| Interaction | NPHP4 interactions | 1.13e-07 | 236 | 21 | 6 | int:NPHP4 | |
| Interaction | KRT2 interactions | 1.13e-07 | 236 | 21 | 6 | int:KRT2 | |
| Interaction | CAND1 interactions | 1.16e-07 | 894 | 21 | 9 | int:CAND1 | |
| Interaction | NMRAL1 interactions | 1.38e-07 | 244 | 21 | 6 | int:NMRAL1 | |
| Interaction | RNF8 interactions | 1.49e-07 | 421 | 21 | 7 | int:RNF8 | |
| Interaction | KRT17 interactions | 1.67e-07 | 252 | 21 | 6 | int:KRT17 | |
| Interaction | CHD4 interactions | 1.75e-07 | 938 | 21 | 9 | int:CHD4 | |
| Interaction | KRT8 interactions | 2.04e-07 | 441 | 21 | 7 | int:KRT8 | |
| Interaction | RPS6KB2 interactions | 2.05e-07 | 261 | 21 | 6 | int:RPS6KB2 | |
| Interaction | DIRAS2 interactions | 2.28e-07 | 52 | 21 | 4 | int:DIRAS2 | |
| Interaction | NDN interactions | 2.45e-07 | 453 | 21 | 7 | int:NDN | |
| Interaction | TRIM31 interactions | 2.49e-07 | 454 | 21 | 7 | int:TRIM31 | |
| Interaction | KRT24 interactions | 2.66e-07 | 54 | 21 | 4 | int:KRT24 | |
| Interaction | MKS1 interactions | 2.70e-07 | 139 | 21 | 5 | int:MKS1 | |
| Interaction | DCUN1D1 interactions | 2.79e-07 | 275 | 21 | 6 | int:DCUN1D1 | |
| Interaction | RIN3 interactions | 2.84e-07 | 463 | 21 | 7 | int:RIN3 | |
| Interaction | KRT19 interactions | 3.24e-07 | 282 | 21 | 6 | int:KRT19 | |
| Interaction | ARL4D interactions | 3.45e-07 | 146 | 21 | 5 | int:ARL4D | |
| Interaction | MYCN interactions | 3.67e-07 | 1373 | 21 | 10 | int:MYCN | |
| Interaction | EIF4A3 interactions | 4.71e-07 | 499 | 21 | 7 | int:EIF4A3 | |
| Interaction | UBASH3B interactions | 4.95e-07 | 157 | 21 | 5 | int:UBASH3B | |
| Interaction | CHD3 interactions | 5.03e-07 | 757 | 21 | 8 | int:CHD3 | |
| Interaction | VIM interactions | 7.94e-07 | 804 | 21 | 8 | int:VIM | |
| Interaction | FAF1 interactions | 8.72e-07 | 334 | 21 | 6 | int:FAF1 | |
| Interaction | KRT15 interactions | 9.22e-07 | 178 | 21 | 5 | int:KRT15 | |
| Interaction | KRT36 interactions | 9.56e-07 | 74 | 21 | 4 | int:KRT36 | |
| Interaction | PHTF1 interactions | 1.10e-06 | 20 | 21 | 3 | int:PHTF1 | |
| Interaction | THRB interactions | 1.15e-06 | 186 | 21 | 5 | int:THRB | |
| Interaction | FN1 interactions | 1.19e-06 | 848 | 21 | 8 | int:FN1 | |
| Interaction | MEPCE interactions | 1.31e-06 | 859 | 21 | 8 | int:MEPCE | |
| Interaction | WTAP interactions | 1.41e-06 | 194 | 21 | 5 | int:WTAP | |
| Interaction | CUL2 interactions | 1.46e-06 | 591 | 21 | 7 | int:CUL2 | |
| Interaction | CUL1 interactions | 1.52e-06 | 876 | 21 | 8 | int:CUL1 | |
| Interaction | ARL16 interactions | 1.52e-06 | 83 | 21 | 4 | int:ARL16 | |
| Interaction | KRT16 interactions | 1.52e-06 | 197 | 21 | 5 | int:KRT16 | |
| Interaction | DDX24 interactions | 1.55e-06 | 596 | 21 | 7 | int:DDX24 | |
| Interaction | IQCB1 interactions | 1.58e-06 | 370 | 21 | 6 | int:IQCB1 | |
| Interaction | KRT76 interactions | 1.59e-06 | 84 | 21 | 4 | int:KRT76 | |
| Interaction | ARAF interactions | 1.74e-06 | 376 | 21 | 6 | int:ARAF | |
| Interaction | LRRC31 interactions | 1.85e-06 | 205 | 21 | 5 | int:LRRC31 | |
| Interaction | KRT3 interactions | 1.92e-06 | 88 | 21 | 4 | int:KRT3 | |
| Interaction | FGD5 interactions | 1.94e-06 | 207 | 21 | 5 | int:FGD5 | |
| Interaction | KRT12 interactions | 1.95e-06 | 24 | 21 | 3 | int:KRT12 | |
| Interaction | MIDN interactions | 2.15e-06 | 626 | 21 | 7 | int:MIDN | |
| Interaction | ALB interactions | 2.18e-06 | 391 | 21 | 6 | int:ALB | |
| Interaction | PTMA interactions | 2.18e-06 | 212 | 21 | 5 | int:PTMA | |
| Interaction | RLIM interactions | 2.21e-06 | 392 | 21 | 6 | int:RLIM | |
| Interaction | NEDD8 interactions | 2.24e-06 | 393 | 21 | 6 | int:NEDD8 | |
| Interaction | KRT33B interactions | 2.39e-06 | 93 | 21 | 4 | int:KRT33B | |
| Interaction | MECP2 interactions | 2.50e-06 | 1287 | 21 | 9 | int:MECP2 | |
| Interaction | RNF31 interactions | 2.59e-06 | 403 | 21 | 6 | int:RNF31 | |
| Interaction | DDX3X interactions | 2.78e-06 | 651 | 21 | 7 | int:DDX3X | |
| Interaction | COPS6 interactions | 2.78e-06 | 408 | 21 | 6 | int:COPS6 | |
| Interaction | TNIP2 interactions | 2.83e-06 | 952 | 21 | 8 | int:TNIP2 | |
| Interaction | KRT37 interactions | 3.20e-06 | 100 | 21 | 4 | int:KRT37 | |
| Interaction | KRT18 interactions | 3.25e-06 | 419 | 21 | 6 | int:KRT18 | |
| Interaction | RC3H2 interactions | 3.27e-06 | 667 | 21 | 7 | int:RC3H2 | |
| Interaction | ARF5 interactions | 3.32e-06 | 231 | 21 | 5 | int:ARF5 | |
| Interaction | RC3H1 interactions | 3.61e-06 | 677 | 21 | 7 | int:RC3H1 | |
| Interaction | AP2M1 interactions | 3.77e-06 | 430 | 21 | 6 | int:AP2M1 | |
| Interaction | EFNA4 interactions | 3.92e-06 | 239 | 21 | 5 | int:EFNA4 | |
| Interaction | FBXL4 interactions | 4.04e-06 | 106 | 21 | 4 | int:FBXL4 | |
| Interaction | KRT35 interactions | 4.85e-06 | 111 | 21 | 4 | int:KRT35 | |
| Interaction | TRAF6 interactions | 5.91e-06 | 465 | 21 | 6 | int:TRAF6 | |
| Interaction | PIH1D1 interactions | 5.98e-06 | 731 | 21 | 7 | int:PIH1D1 | |
| Interaction | VCAM1 interactions | 6.67e-06 | 475 | 21 | 6 | int:VCAM1 | |
| Cytoband | 12q13.13 | 2.43e-08 | 67 | 21 | 4 | 12q13.13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 3.76e-05 | 423 | 21 | 4 | chr12q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | 5.79e-05 | 473 | 21 | 4 | chr17q21 | |
| Cytoband | 2q31.1 | 6.79e-04 | 84 | 21 | 2 | 2q31.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q31 | 2.99e-03 | 178 | 21 | 2 | chr2q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 1.64e-02 | 1192 | 21 | 3 | chr19q13 | |
| GeneFamily | Keratins, type II | 1.51e-08 | 27 | 19 | 4 | 609 | |
| GeneFamily | Keratins, type I | 1.75e-08 | 28 | 19 | 4 | 608 | |
| Coexpression | LIU_CDX2_TARGETS_DN | 2.48e-08 | 8 | 21 | 3 | M19218 | |
| Coexpression | JAEGER_METASTASIS_DN | 4.31e-08 | 260 | 21 | 6 | M10702 | |
| Coexpression | MURAKAMI_UV_RESPONSE_1HR_UP | 2.00e-07 | 15 | 21 | 3 | M13308 | |
| Coexpression | HOLLERN_SQUAMOUS_BREAST_TUMOR | 1.00e-05 | 173 | 21 | 4 | M650 | |
| Coexpression | GSE21360_SECONDARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP | 1.23e-05 | 182 | 21 | 4 | M7624 | |
| Coexpression | HALLMARK_KRAS_SIGNALING_DN | 1.78e-05 | 200 | 21 | 4 | M5956 | |
| Coexpression | HOLLERN_SQUAMOUS_BREAST_TUMOR | 1.92e-05 | 204 | 21 | 4 | MM966 | |
| Coexpression | ZENG_GU_POST_ICB_METAGENE_39 | 1.92e-05 | 204 | 21 | 4 | MM17090 | |
| Coexpression | DESCARTES_FETAL_STOMACH_SQUAMOUS_EPITHELIAL_CELLS | 2.05e-05 | 67 | 21 | 3 | M40299 | |
| Coexpression | BUSSLINGER_ESOPHAGEAL_PROLIFERATING_BASAL_CELLS | 2.34e-05 | 70 | 21 | 3 | M40002 | |
| Coexpression | BUSSLINGER_ESOPHAGEAL_EARLY_SUPRABASAL_CELLS | 3.37e-05 | 79 | 21 | 3 | M40003 | |
| Coexpression | AIZARANI_LIVER_C28_NK_NKT_CELLS_6 | 6.62e-05 | 99 | 21 | 3 | M39127 | |
| Coexpression | TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA | 7.23e-05 | 102 | 21 | 3 | M14455 | |
| Coexpression | DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_OLFACTORY_HORIZONTAL_BASAL_CELLS | 1.04e-04 | 19 | 21 | 2 | M39272 | |
| Coexpression | MURAKAMI_UV_RESPONSE_24HR | 1.15e-04 | 20 | 21 | 2 | M17175 | |
| Coexpression | MURAKAMI_UV_RESPONSE_6HR_DN | 1.27e-04 | 21 | 21 | 2 | M16756 | |
| Coexpression | CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP | 1.35e-04 | 126 | 21 | 3 | M12795 | |
| Coexpression | KRAS.300_UP.V1_DN | 1.85e-04 | 140 | 21 | 3 | M2874 | |
| Coexpression | KRAS.LUNG_UP.V1_DN | 1.93e-04 | 142 | 21 | 3 | M2893 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_MID_BASAL_CELL | 2.22e-04 | 149 | 21 | 3 | M45703 | |
| Coexpression | SHIN_B_CELL_LYMPHOMA_CLUSTER_3 | 2.28e-04 | 28 | 21 | 2 | M1387 | |
| Coexpression | SHIN_B_CELL_LYMPHOMA_CLUSTER_3 | 2.28e-04 | 28 | 21 | 2 | MM1134 | |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS | 3.27e-04 | 786 | 21 | 5 | M2388 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP | 4.07e-04 | 450 | 21 | 4 | M1350 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_CD4_POSITIVE_ALPHA_BETA_T_CELL_AGEING | 4.53e-04 | 190 | 21 | 3 | MM3832 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_BASAL_CELL | 4.74e-04 | 193 | 21 | 3 | M45706 | |
| Coexpression | GSE45837_WT_VS_GFI1_KO_PDC_UP | 4.89e-04 | 195 | 21 | 3 | M9892 | |
| Coexpression | GSE11864_CSF1_PAM3CYS_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP | 4.96e-04 | 196 | 21 | 3 | M3148 | |
| Coexpression | GSE360_L_MAJOR_VS_M_TUBERCULOSIS_MAC_UP | 4.96e-04 | 196 | 21 | 3 | M5252 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_NKCELL_DN | 5.11e-04 | 198 | 21 | 3 | M5421 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_EFF_MEMORY_CD4_TCELL_DN | 5.11e-04 | 198 | 21 | 3 | M5417 | |
| Coexpression | GSE19401_NAIVE_VS_IMMUNIZED_MOUSE_PLN_FOLLICULAR_DC_UP | 5.18e-04 | 199 | 21 | 3 | M7656 | |
| Coexpression | GSE17721_CPG_VS_GARDIQUIMOD_0.5H_BMDC_UP | 5.18e-04 | 199 | 21 | 3 | M3876 | |
| Coexpression | GSE360_CTRL_VS_L_DONOVANI_MAC_DN | 5.18e-04 | 199 | 21 | 3 | M5159 | |
| Coexpression | GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN | 5.18e-04 | 199 | 21 | 3 | M3460 | |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS | 5.23e-04 | 871 | 21 | 5 | MM1005 | |
| Coexpression | GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_24H_IFNG_STIM_DN | 5.26e-04 | 200 | 21 | 3 | M6309 | |
| Coexpression | GSE22196_HEALTHY_VS_OBESE_MOUSE_SKIN_GAMMADELTA_TCELL_DN | 5.26e-04 | 200 | 21 | 3 | M7653 | |
| Coexpression | GSE17721_POLYIC_VS_PAM3CSK4_2H_BMDC_DN | 5.26e-04 | 200 | 21 | 3 | M3831 | |
| Coexpression | GSE27670_CTRL_VS_BLIMP1_TRANSDUCED_GC_BCELL_UP | 5.26e-04 | 200 | 21 | 3 | M8212 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP | 5.61e-04 | 490 | 21 | 4 | MM1001 | |
| Coexpression | KIM_WT1_TARGETS_UP | 6.67e-04 | 217 | 21 | 3 | M9128 | |
| Coexpression | CROMER_TUMORIGENESIS_DN | 7.03e-04 | 49 | 21 | 2 | M16948 | |
| Coexpression | DESCARTES_FETAL_EYE_CORNEAL_AND_CONJUNCTIVAL_EPITHELIAL_CELLS | 9.36e-04 | 244 | 21 | 3 | M40175 | |
| Coexpression | BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_DN | 1.02e-03 | 59 | 21 | 2 | M34021 | |
| Coexpression | ONDER_CDH1_TARGETS_3_DN | 1.02e-03 | 59 | 21 | 2 | M11790 | |
| CoexpressionAtlas | skin | 6.78e-09 | 456 | 21 | 8 | skin | |
| CoexpressionAtlas | UniversalReference_WholeMouseP1_top-relative-expression-ranked_250 | 1.47e-06 | 206 | 21 | 5 | Facebase_ST1_Univ_250 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_k-means-cluster#3_top-relative-expression-ranked_500 | 1.89e-06 | 25 | 21 | 3 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_500_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_top-relative-expression-ranked_500 | 2.00e-06 | 406 | 21 | 6 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_500 | |
| CoexpressionAtlas | UniversalReference_WholeMouseP1_top-relative-expression-ranked_500 | 2.68e-06 | 427 | 21 | 6 | Facebase_ST1_Univ_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_200 | 4.46e-06 | 33 | 21 | 3 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#4_top-relative-expression-ranked_200 | 7.45e-06 | 39 | 21 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_200_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_top-relative-expression-ranked_1000 | 8.00e-06 | 805 | 21 | 7 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_1000 | |
| CoexpressionAtlas | dev lower uro neuro_e14.5_PelvicGanglion_Sox10_k-means-cluster#3_top-relative-expression-ranked_500 | 1.08e-05 | 44 | 21 | 3 | gudmap_dev lower uro neuro_e14.5_PelvicGanglion_Sox10_k3_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#1_top-relative-expression-ranked_500 | 1.31e-05 | 47 | 21 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.23e-05 | 56 | 21 | 3 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k4_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#1_top-relative-expression-ranked_500 | 2.89e-05 | 61 | 21 | 3 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k1_500 | |
| CoexpressionAtlas | dev lower uro neuro_e14.5_PelvicGanglion_Sox10_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.19e-05 | 63 | 21 | 3 | gudmap_dev lower uro neuro_e14.5_PelvicGanglion_Sox10_k2_1000 | |
| CoexpressionAtlas | BM Top 100 - trachea | 4.76e-05 | 72 | 21 | 3 | BM Top 100 - trachea | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#1_top-relative-expression-ranked_100 | 5.10e-05 | 11 | 21 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_100_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#1_top-relative-expression-ranked_500 | 6.05e-05 | 78 | 21 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#5_top-relative-expression-ranked_1000 | 6.05e-05 | 78 | 21 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#5_top-relative-expression-ranked_100 | 6.11e-05 | 12 | 21 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_100_k5 | |
| CoexpressionAtlas | Myeloid Cells, DC.LC.Sk, MHCII+ CD11b+ CD45+, Skin, avg-2 | 6.49e-05 | 451 | 21 | 5 | GSM538280_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | 7.53e-05 | 769 | 21 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 | |
| CoexpressionAtlas | UniversalReference_WholeMouseP1_top-relative-expression-ranked_100 | 7.54e-05 | 84 | 21 | 3 | Facebase_ST1_Univ_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_top-relative-expression-ranked_100 | 8.38e-05 | 87 | 21 | 3 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_100 | 8.42e-05 | 14 | 21 | 2 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_100 | 8.96e-05 | 89 | 21 | 3 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_100 | |
| CoexpressionAtlas | esophagus | 9.15e-05 | 247 | 21 | 4 | esophagus | |
| CoexpressionAtlas | Myeloid Cells, DC.LC.Sk, MHCII+ CD11b+ CD45+, Skin, avg-2 | 9.58e-05 | 91 | 21 | 3 | GSM538280_100 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchioEpithel_top-relative-expression-ranked_100 | 1.19e-04 | 98 | 21 | 3 | PCBC_ctl_BronchioEpithel_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_k-means-cluster#3_top-relative-expression-ranked_100 | 1.58e-04 | 19 | 21 | 2 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_100_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.59e-04 | 108 | 21 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#1_top-relative-expression-ranked_200 | 1.93e-04 | 21 | 21 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_200_k1 | |
| CoexpressionAtlas | PP_MEP_top-relative-expression-ranked_500_k-means-cluster#5 | 1.93e-04 | 21 | 21 | 2 | PP_MEP_500_K5 | |
| CoexpressionAtlas | dev lower uro neuro_e14.5_PelvicGanglion_Sox10_k-means-cluster#1_top-relative-expression-ranked_200 | 2.13e-04 | 22 | 21 | 2 | gudmap_dev lower uro neuro_e14.5_PelvicGanglion_Sox10_k1_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.17e-04 | 120 | 21 | 3 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k1_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#2_top-relative-expression-ranked_200 | 2.33e-04 | 23 | 21 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_200_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_100 | 2.33e-04 | 23 | 21 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_100_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#1_top-relative-expression-ranked_200 | 2.54e-04 | 24 | 21 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_200_k1 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_2500_k-means-cluster#3 | 2.62e-04 | 325 | 21 | 4 | Arv_EB-LF_2500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K1 | 2.81e-04 | 131 | 21 | 3 | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#1_top-relative-expression-ranked_500 | 3.47e-04 | 28 | 21 | 2 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k1_500 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K1 | 4.19e-04 | 150 | 21 | 3 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#5_top-relative-expression-ranked_500 | 4.83e-04 | 33 | 21 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_500 | 5.24e-04 | 390 | 21 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_200 | 5.53e-04 | 165 | 21 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_top-relative-expression-ranked_500 | 5.81e-04 | 401 | 21 | 4 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_top-relative-expression-ranked_200 | 5.83e-04 | 168 | 21 | 3 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_200 | 6.03e-04 | 170 | 21 | 3 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_200 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_200 | 6.41e-04 | 38 | 21 | 2 | gudmap_developingGonad_e11.5_ovary + mesonephros_k2_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_k-means-cluster#5_top-relative-expression-ranked_200 | 6.75e-04 | 39 | 21 | 2 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_200_k5 | |
| CoexpressionAtlas | mendel_RNAseq_e18.5_Urothelium_Krt5CreRFP_2500_K2 | 7.29e-04 | 426 | 21 | 4 | mendel_RNAseq_e18.5_Urothelium_Krt5CreRFP_2500_K2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder urothelium (LCM)_emap-30380_k-means-cluster#3_top-relative-expression-ranked_200 | 7.46e-04 | 41 | 21 | 2 | gudmap_developingLowerUrinaryTract_P2_bladder urothelium (LCM)_200_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_500_k-means-cluster#4 | 8.59e-04 | 44 | 21 | 2 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_500_K4 | |
| CoexpressionAtlas | PP_MEP_top-relative-expression-ranked_1000_k-means-cluster#5 | 8.99e-04 | 45 | 21 | 2 | PP_MEP_1000_K5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_top-relative-expression-ranked_1000 | 9.22e-04 | 800 | 21 | 5 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#5_top-relative-expression-ranked_500 | 9.80e-04 | 47 | 21 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.07e-03 | 49 | 21 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_k-means-cluster#4_top-relative-expression-ranked_500 | 1.20e-03 | 52 | 21 | 2 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_500_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_k-means-cluster#5_top-relative-expression-ranked_500 | 1.25e-03 | 53 | 21 | 2 | gudmap_developingLowerUrinaryTract_adult_bladder_500_k5 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#4_top-relative-expression-ranked_200 | 1.29e-03 | 54 | 21 | 2 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k4_200 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_200 | 1.49e-03 | 58 | 21 | 2 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.49e-03 | 58 | 21 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#3_top-relative-expression-ranked_500 | 1.54e-03 | 59 | 21 | 2 | gudmap_developingLowerUrinaryTract_P1_bladder_B_500_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 1.65e-03 | 61 | 21 | 2 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.79e-03 | 248 | 21 | 3 | Facebase_RNAseq_e8.5_Floor Plate_1000_K4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#3_top-relative-expression-ranked_500 | 1.92e-03 | 66 | 21 | 2 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_500_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_k-means-cluster#4_top-relative-expression-ranked_500 | 2.16e-03 | 70 | 21 | 2 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_500_k4 | |
| CoexpressionAtlas | BM Top 100 - tonsil | 2.16e-03 | 70 | 21 | 2 | BM Top 100 - tonsil | |
| CoexpressionAtlas | mendel_RNAseq_e17.5_Urothelium_ShhCreRFP_2500_K1 | 2.34e-03 | 987 | 21 | 5 | mendel_RNAseq_e17.5_Urothelium_ShhCreRFP_2500_K1 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_100 | 2.35e-03 | 73 | 21 | 2 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.35e-03 | 73 | 21 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#1_top-relative-expression-ranked_500 | 2.48e-03 | 75 | 21 | 2 | gudmap_developingLowerUrinaryTract_P1_bladder_J_500_k1 | |
| CoexpressionAtlas | BM Top 100 - bronchus | 2.54e-03 | 76 | 21 | 2 | BM Top 100 - bronchus | |
| CoexpressionAtlas | BM Top 100 - urethra | 2.61e-03 | 77 | 21 | 2 | BM Top 100 - urethra | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_100 | 2.67e-03 | 78 | 21 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_top-relative-expression-ranked_100 | 2.67e-03 | 78 | 21 | 2 | gudmap_developingKidney_e15.5_Cap mesenchyme_100 | |
| CoexpressionAtlas | BM Top 100 - tongue superior part w_papillae | 2.74e-03 | 79 | 21 | 2 | BM Top 100 - tongue superior part w_papillae | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_100 | 2.74e-03 | 79 | 21 | 2 | gudmap_developingGonad_e11.5_ovary + mesonephros_100 | |
| CoexpressionAtlas | BM Top 100 - tongue main corpus | 2.81e-03 | 80 | 21 | 2 | BM Top 100 - tongue main corpus | |
| CoexpressionAtlas | UniversalReference_WholeMouseP1_top-relative-expression-ranked_500_3 | 2.95e-03 | 82 | 21 | 2 | Facebase_ST1_Univ_500_3 | |
| CoexpressionAtlas | BM Top 100 - oral mucosa | 3.02e-03 | 83 | 21 | 2 | BM Top 100 - oral mucosa | |
| CoexpressionAtlas | BM Top 100 - nipple cross-section | 3.09e-03 | 84 | 21 | 2 | BM Top 100 - nipple cross-section | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_100 | 3.17e-03 | 85 | 21 | 2 | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_100 | |
| CoexpressionAtlas | BM Top 100 - esophagus | 3.24e-03 | 86 | 21 | 2 | BM Top 100 - esophagus | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_100 | 3.24e-03 | 86 | 21 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_100 | |
| CoexpressionAtlas | ratio_induced-DefinitiveEndoderm_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#3 | 3.65e-03 | 319 | 21 | 3 | ratio_DE_vs_SC_1000_K3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.70e-03 | 92 | 21 | 2 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_1000_k3 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-10 | 185 | 21 | 6 | eb7d3c1363d5fedc611f9c1a91ea823de251355e | |
| ToppCell | TCGA-Stomach-Solid_Tissue_Normal-Stomach_normal_tissue-Stomach_normal_tissue-4|TCGA-Stomach / Sample_Type by Project: Shred V9 | 9.44e-09 | 157 | 21 | 5 | 2553ebf3e48de5bd184e77bd61114faa5a1d95ed | |
| ToppCell | Skin|World / Skin and Kidney Cells in Lupus Nephritis Patients. | 3.09e-08 | 199 | 21 | 5 | 6be1340413ee868c610b6e3f58c65b493eb22bb5 | |
| ToppCell | Kidney-Keratinocytes|Kidney / Skin and Kidney Cells in Lupus Nephritis Patients. | 3.17e-08 | 200 | 21 | 5 | 41d83faa9f45ee7ea2ab19be8ecc6d2c5ac7fe5d | |
| ToppCell | Skin-Keratinocytes|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 3.17e-08 | 200 | 21 | 5 | 59d72395199bc30df0e811fbc99149694e208860 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.62e-07 | 149 | 21 | 4 | d259e9137109eeb2662022f0915ca463f5bebdfe | |
| ToppCell | facs-Lung-Endomucin-24m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.24e-07 | 162 | 21 | 4 | 497ae9f86a5e7946d0fde932b35719a382a6b691 | |
| ToppCell | facs-Lung-Endomucin-24m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.24e-07 | 162 | 21 | 4 | 7b2949eba2b4aea239d96ed82aafab13b07624eb | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.32e-06 | 177 | 21 | 4 | aadf1d10eccfb014cf3d621b1f01dd6d76df63ac | |
| ToppCell | droplet-Skin|droplet / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-06 | 185 | 21 | 4 | 657fd191ed160f8620d57b33820ec7222806f289 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.57e-06 | 185 | 21 | 4 | e0172e0ab0f1d7151a3c3c63bb7c84d6bda92035 | |
| ToppCell | facs-SCAT-Fat-3m|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-06 | 188 | 21 | 4 | b8dff61240e5052c2fbf7f28b86fe41822df45b0 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.71e-06 | 189 | 21 | 4 | c80610395d016acc855cfa451e47ea6cecb0556c | |
| ToppCell | TCGA-Skin-Primary_Tumor|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.74e-06 | 190 | 21 | 4 | e2b26a03c6ab24d9b0f4150c47597be37767d86e | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.74e-06 | 190 | 21 | 4 | 01fb45add4661bc86cd0a34fac35177907152dbb | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.74e-06 | 190 | 21 | 4 | 83eb0151226b3f5a7dae994a1a519285f9bf6e82 | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.74e-06 | 190 | 21 | 4 | 3188c7bd225cbcf46a21e2fb784336cdd9665995 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.78e-06 | 191 | 21 | 4 | c5aaf795dccc94ff0c66d08d5525abe2a5f8b98e | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.82e-06 | 192 | 21 | 4 | 24fb2f1e6f49ab5b71876e105c0ee7f59e7d64e8 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_monocytic|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.97e-06 | 196 | 21 | 4 | 03de28e1c963e99623e8b0e33bf2e8ef67dc3baa | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.01e-06 | 197 | 21 | 4 | 8623972c7a70b3565b7a3a4afe93f1e012008201 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_monocytic-leukocyte|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.01e-06 | 197 | 21 | 4 | e621d4f9d4ba5e3ef17d2b477e5e14ea0251147e | |
| ToppCell | Bronchus_Control_(B.)|World / Sample group, Lineage and Cell type | 2.01e-06 | 197 | 21 | 4 | b6dff2ee108813e18657e2d8cf850e2423f8c8e9 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.05e-06 | 198 | 21 | 4 | f088badb90c6c2d916195f5649eda102119c9ac6 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.10e-06 | 199 | 21 | 4 | ba284f984909504221900bca5ea12ada5b2ffd9f | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)|Smart-seq2 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.10e-06 | 199 | 21 | 4 | 8be7cb9d8b4f9707efb69c681c40e683fcd810e5 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Pax6|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.02e-05 | 130 | 21 | 3 | 60e28d452d0e2af768459ba8dbe998117c94a251 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Krt73|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.09e-05 | 131 | 21 | 3 | 9ca209a8652aae603c4a867ea06b06ac51e7d189 | |
| ToppCell | ASK440-Epithelial-Secretory|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.93e-05 | 142 | 21 | 3 | ea694a907eaa46c55665692cb830870281700e40 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.09e-05 | 144 | 21 | 3 | e2a2f260f5ebaaef46248d199c407a15ce9d024a | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.44e-05 | 148 | 21 | 3 | afebb64365c94b9476494bffe7c364677f19c8cf | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Fam159b|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.44e-05 | 148 | 21 | 3 | 9205b26e0d042b342cc643cda0f4f3f8bb392d00 | |
| ToppCell | Thalamus-Neuronal-Inhibitory|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.44e-05 | 148 | 21 | 3 | 5f82e5ecacfd223020b8ee975c17d68c1fe6db38 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.62e-05 | 150 | 21 | 3 | aa11579a57d671a55e64183d35c1340fda6dec14 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.90e-05 | 153 | 21 | 3 | 82b77c8bae49dd63b8f10eb67df66ca71d0bb315 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Basal_2|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.90e-05 | 153 | 21 | 3 | a44da11a913b19edde6c5d1d6e625c24b20ecbfd | |
| ToppCell | facs-MAT-Fat-24m|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.19e-05 | 156 | 21 | 3 | 7433c6d4eb4d061844d8979c1e648d8ed56e1073 | |
| ToppCell | facs-MAT-Fat-24m-Epithelial|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-05 | 157 | 21 | 3 | a47d102570e82d34ea1a8756f82636e7ab27c07f | |
| ToppCell | 343B-Epithelial_cells-Epithelial-H_(AT1)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.29e-05 | 157 | 21 | 3 | dd08dc19d434e94a194076c462ee273c682abf55 | |
| ToppCell | facs-MAT-Fat-24m-Epithelial-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-05 | 157 | 21 | 3 | 30814ff90cead688ef64dac4cf4a6d63756d8944 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-H_(AT1)|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.29e-05 | 157 | 21 | 3 | 70fd6c46db4250c7de5c4686a9500689402737f6 | |
| ToppCell | facs-MAT-Fat-24m-Epithelial-epithelial_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-05 | 157 | 21 | 3 | 7c20f225b2db8b340f4fec050ff29e666b860f04 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-basal_intermediate_|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.39e-05 | 158 | 21 | 3 | 98712ed7e8e65e8c5ff9318cf0e0a04e271a055d | |
| ToppCell | 390C-Epithelial_cells-Epithelial-H_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells) | 5.60e-05 | 160 | 21 | 3 | 830f17bad94de05612fe6d53d39e42a4b3f3e2f3 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-H_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 5.60e-05 | 160 | 21 | 3 | 18ae6822915d16699beb9047baeef9b006901a35 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.60e-05 | 160 | 21 | 3 | 8590281165eab6514a9f6a022b900d4c222c1044 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-4|TCGA-Stomach / Sample_Type by Project: Shred V9 | 5.92e-05 | 163 | 21 | 3 | 6a12b802cb181f979ebc72674f3626fb855024e3 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Basal-Basal-Basal_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.36e-05 | 167 | 21 | 3 | 29d271643f3a1718b53db77b7d093ec94225a824 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-05 | 168 | 21 | 3 | 04a7810f95196a21325356b42084f96c11af5964 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Basal-Basal-Basal_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.47e-05 | 168 | 21 | 3 | f150beee37e0252951a88adcd9e3f0a22e5cfdd9 | |
| ToppCell | Basal_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 6.47e-05 | 168 | 21 | 3 | 48089fa2d4a0f31a72405717119b767a92571f01 | |
| ToppCell | facs-Tongue-nan-24m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.59e-05 | 169 | 21 | 3 | 0054f9bfd4d377c7fd94873c1308622051c59a8e | |
| ToppCell | 15-Airway-Epithelial-Submucosal_gland_basal|Airway / Age, Tissue, Lineage and Cell class | 6.70e-05 | 170 | 21 | 3 | 61f8dd5e27df1b8d01ccfd0d25247b34aa8d182c | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.70e-05 | 170 | 21 | 3 | 2d880223d01bde4bf777bd6f50b7d2768489075f | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.70e-05 | 170 | 21 | 3 | 0cc20322cb3e3e7bbd4daad8785c99f80e355c16 | |
| ToppCell | TCGA-Cervix|World / Sample_Type by Project: Shred V9 | 6.70e-05 | 170 | 21 | 3 | a6cbe253bc60f5d5cb361c7e85ed9928a3155ec8 | |
| ToppCell | facs-Trachea-nan-24m-Epithelial-basal_epithelial_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.82e-05 | 171 | 21 | 3 | d2a10e94b0490120d1420b944302eb841f902c64 | |
| ToppCell | facs-Heart-RV-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.94e-05 | 172 | 21 | 3 | a26a73c41e5a05c9dd47a99f3320295f684c5e54 | |
| ToppCell | 11.5-Airway-Epithelial-Basal_cell|Airway / Age, Tissue, Lineage and Cell class | 6.94e-05 | 172 | 21 | 3 | 9d4d92e2d16dfc8a394f2641653bb97de20a2530 | |
| ToppCell | Striatum|World / BrainAtlas - Mouse McCarroll V32 | 6.94e-05 | 172 | 21 | 3 | 8da598d209b8a6646b9f4de1aed833f6fcbb9909 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-H_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.94e-05 | 172 | 21 | 3 | bb542f6ca4eb8167129bc84ca1160a54fbb68731 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Basal/Suprabasal-Basal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.94e-05 | 172 | 21 | 3 | e9095c3dac66cf93d31f5f88364b565abacb1e2d | |
| ToppCell | 390C-Epithelial_cells-Epithelial-H_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.94e-05 | 172 | 21 | 3 | aff37b9689b0d30ee7097d997d9588efc475c8fd | |
| ToppCell | TCGA-Head_and_Esophagus|World / Sample_Type by Project: Shred V9 | 6.94e-05 | 172 | 21 | 3 | eb18aa179db1818f408c38e442ecfed8582d7dbc | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Basal-Basal-Basal_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.06e-05 | 173 | 21 | 3 | 1b2508cc890430bd4b2cf232c633928edb86c57e | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Basal-Basal-Basal_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.18e-05 | 174 | 21 | 3 | 97d4a40b536a67fa52f055eab26106d041bf3220 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Basal-Basal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.18e-05 | 174 | 21 | 3 | f9f399244c7d12caf8118ec3117d477a39e35c3b | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Basal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.18e-05 | 174 | 21 | 3 | e8440eea7c81864defa57c89e9b569ad8033e5c5 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.18e-05 | 174 | 21 | 3 | 207aa0118633cbe9a65839bbb1bb3ba9f8118ad2 | |
| ToppCell | facs-Heart-RV-18m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.31e-05 | 175 | 21 | 3 | bde002379088c0407afd0f3dae60b6a166683957 | |
| ToppCell | facs-Trachea-nan-18m-Epithelial-basal_epithelial_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.31e-05 | 175 | 21 | 3 | eb87275da6f61ecb4fbc89421dfd27bead1e0f48 | |
| ToppCell | facs-Trachea-nan-18m-Epithelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.31e-05 | 175 | 21 | 3 | 3883675a726dd0c6c3a7113d59be2a093ea2dc6f | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Proximal_secretory_3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.43e-05 | 176 | 21 | 3 | 8d9d0fb46c418b2067be58aec822e8c2b1561461 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-SMG_basal_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.43e-05 | 176 | 21 | 3 | 045b12c90f7dd49a9778dadcdf8f18125b380531 | |
| ToppCell | facs-GAT-Fat-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.43e-05 | 176 | 21 | 3 | acd05ca8952710feedbfe377b1330f3c2406d044 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.56e-05 | 177 | 21 | 3 | 9e65b39fd797b6ce204b6480415810d1923acee5 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-5|TCGA-Lung / Sample_Type by Project: Shred V9 | 7.56e-05 | 177 | 21 | 3 | a0c7d08469c513cecf87777c19876884f1511570 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.68e-05 | 178 | 21 | 3 | 6d9ecfaeb50d562899380de379ebf7b99fd8adc9 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.68e-05 | 178 | 21 | 3 | d3f518cd75b02e85d45cbb9b2eff30f0272512a8 | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.68e-05 | 178 | 21 | 3 | 89f0537459a321ded956bf70ad56fefc0854f8b0 | |
| ToppCell | facs-Bladder-nan-24m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.81e-05 | 179 | 21 | 3 | fc9f44fb81da0d381a5141a95a005e66a0be28cc | |
| ToppCell | facs-Bladder-nan-24m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.81e-05 | 179 | 21 | 3 | 9152d92bb96e65d43de54e933494f0d08ae02c4f | |
| ToppCell | facs-Kidney-nan-3m-Epithelial-kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.94e-05 | 180 | 21 | 3 | fc5b9d0e3215652e490ca72d69f776e9725608b2 | |
| ToppCell | facs-Kidney-nan-3m-Epithelial-kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.94e-05 | 180 | 21 | 3 | 6763b22f2383931c747b37cd0ae2f60b08f64d90 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Basal-Basal|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.07e-05 | 181 | 21 | 3 | 6b43dcaeeb02ad5900772b6f16f1581847050e38 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.07e-05 | 181 | 21 | 3 | 41969fe4d94ee77b12ecde32170aaf0b13e49644 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.07e-05 | 181 | 21 | 3 | 3f50e61dc2a52d71a5801584617607e6246adcf2 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Basal|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.07e-05 | 181 | 21 | 3 | f50561fdacfb83ba85fe6476e7cbc2bad1ebc826 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.21e-05 | 182 | 21 | 3 | 678eadd57e7e830fc2bf9fd35616d3badce01705 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell-Papillary_Tip_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.21e-05 | 182 | 21 | 3 | 8d1229fa5aa6e2e38f2ac6fe4f4dc89752fe9344 | |
| ToppCell | facs-Kidney-nan-3m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.21e-05 | 182 | 21 | 3 | 4c5d14e33ebdf117b5aa9e2f57aaa89aa51f72bf | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.34e-05 | 183 | 21 | 3 | 824ecda1219fb596a01bf5cfeee29a6daa462098 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.34e-05 | 183 | 21 | 3 | 82b84ee065fb573688d59da97a327152a1ba294c | |
| ToppCell | wk_20-22-Mesenchymal-Mesothelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 8.48e-05 | 184 | 21 | 3 | 804f8a41cd6b1361448872bf352bf0a38a0fac66 | |
| ToppCell | facs-Skin-nan-18m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.48e-05 | 184 | 21 | 3 | dc7f6ee4062856a02423fff8b1cce62d46a9355c | |
| ToppCell | wk_20-22-Mesenchymal-Mesothelial-Late_mesothelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 8.48e-05 | 184 | 21 | 3 | 60dd055c2e2e92b838ac649c12e8cccd9c3b1b71 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-basal_proximal|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 8.48e-05 | 184 | 21 | 3 | 575de705053da8b289670b5c40c1627c0833b5ed | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.61e-05 | 185 | 21 | 3 | 98547c1b1828b76da810ed86082182afaaacdb3f | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.61e-05 | 185 | 21 | 3 | 492529121cb9e88bd3c0db6b54af3cd2979572bc | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.61e-05 | 185 | 21 | 3 | 5f5df92b328be396941b5812d00454b5ff927d30 | |
| Computational | Genes in the cancer module 68. | 6.26e-10 | 26 | 19 | 5 | MODULE_68 | |
| Computational | Keratin. | 6.26e-10 | 26 | 19 | 5 | MODULE_298 | |
| Computational | Genes in the cancer module 153. | 3.13e-07 | 34 | 19 | 4 | MODULE_153 | |
| Computational | Intermediate filaments and keratins. | 1.01e-05 | 80 | 19 | 4 | MODULE_357 | |
| Computational | Genes in the cancer module 297. | 1.01e-05 | 80 | 19 | 4 | MODULE_297 | |
| Computational | Developmental processes. | 1.63e-05 | 333 | 19 | 6 | MODULE_220 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 8.71e-05 | 50 | 19 | 3 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPISEN | |
| Computational | Genes in the cancer module 181. | 1.51e-04 | 306 | 19 | 5 | MODULE_181 | |
| Computational | Intermediate filaments and MT. | 2.18e-04 | 68 | 19 | 3 | MODULE_438 | |
| Computational | Intermediate filaments. | 2.92e-04 | 75 | 19 | 3 | MODULE_154 | |
| Computational | Genes in the cancer module 104. | 2.95e-04 | 353 | 19 | 5 | MODULE_104 | |
| Computational | Genes in the cancer module 41. | 2.50e-03 | 566 | 19 | 5 | MODULE_41 | |
| Computational | Neighborhood of ESR1 | 3.23e-03 | 172 | 19 | 3 | MORF_ESR1 | |
| Computational | Genes in the cancer module 197. | 3.34e-03 | 174 | 19 | 3 | MODULE_197 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.45e-03 | 50 | 19 | 2 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_EMT_LIKE_1 | |
| Drug | teleocidin B | 1.11e-13 | 123 | 21 | 8 | CID000072425 | |
| Drug | sulfur mustard | 1.74e-13 | 130 | 21 | 8 | CID000010461 | |
| Drug | homocysteine thiolactone | 1.85e-13 | 131 | 21 | 8 | CID000107712 | |
| Drug | al-Badry | 1.20e-12 | 165 | 21 | 8 | CID000004545 | |
| Drug | AC1L9MJT | 4.09e-12 | 192 | 21 | 8 | CID000448959 | |
| Drug | Velcade (bortezomib | 1.95e-11 | 374 | 21 | 9 | CID000093860 | |
| Drug | olomoucine II | 3.18e-11 | 27 | 21 | 5 | CID005494414 | |
| Drug | 1-2q | 1.08e-10 | 289 | 21 | 8 | CID000011820 | |
| Drug | CK 6 | 1.77e-09 | 58 | 21 | 5 | CID000447960 | |
| Drug | adenosine 3',5'-cyclic phosphate | 2.27e-09 | 907 | 21 | 10 | CID000000274 | |
| Drug | butyrate | 1.09e-08 | 767 | 21 | 9 | CID000000264 | |
| Drug | phenyl isocyanate | 1.35e-08 | 6 | 21 | 3 | ctd:C025319 | |
| Drug | AC1L1GT5 | 2.19e-08 | 95 | 21 | 5 | CID000003829 | |
| Drug | Chromates | 5.66e-08 | 9 | 21 | 3 | ctd:D002840 | |
| Drug | phorbol acetate myristate | 1.40e-07 | 1399 | 21 | 10 | CID000004792 | |
| Drug | NSC34533 | 1.64e-07 | 54 | 21 | 4 | CID000003512 | |
| Drug | CK17 | 2.05e-07 | 57 | 21 | 4 | CID000128831 | |
| Drug | K-11 | 4.56e-07 | 17 | 21 | 3 | CID000469667 | |
| Drug | antipsoriatic | 4.99e-07 | 71 | 21 | 4 | CID000005585 | |
| Drug | dithranol | 5.47e-07 | 18 | 21 | 3 | CID000002202 | |
| Drug | ethylnylestradiol | 7.15e-07 | 1251 | 21 | 9 | CID000003285 | |
| Drug | 1pxm | 7.30e-07 | 78 | 21 | 4 | CID000447959 | |
| Drug | beta-damascenone | 1.35e-06 | 24 | 21 | 3 | ctd:C075388 | |
| Drug | Bi-E | 1.95e-06 | 27 | 21 | 3 | CID006914595 | |
| Drug | [(2R,3R,4R,5S,6R)-2-[[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-5-hydroxy-6-(hydroxymethyl)-3-[(2-tritioacetyl)amino]oxan-4-yl] (3R)-3-hydroxydecanoate | 2.18e-06 | 28 | 21 | 3 | CID011650719 | |
| Drug | Morphine | 2.31e-06 | 446 | 21 | 6 | ctd:D009020 | |
| Drug | AC1NQZM2 | 2.43e-06 | 29 | 21 | 3 | CID005282177 | |
| Drug | K-13 | 2.99e-06 | 31 | 21 | 3 | CID000469669 | |
| Drug | bexarotene | 3.00e-06 | 111 | 21 | 4 | CID000082146 | |
| Drug | 4-oxoretinoic acid | 3.46e-06 | 115 | 21 | 4 | ctd:C002202 | |
| Drug | CD367 | 3.62e-06 | 33 | 21 | 3 | CID000119342 | |
| Drug | bromovanin | 5.13e-06 | 127 | 21 | 4 | ctd:C515564 | |
| Drug | I5B1 | 5.15e-06 | 37 | 21 | 3 | CID005487705 | |
| Drug | DMBA | 7.56e-06 | 140 | 21 | 4 | CID000006001 | |
| Drug | sandostatinLAR | 8.22e-06 | 143 | 21 | 4 | ctd:C541923 | |
| Drug | 2,4-diacetylphloroglucinol | 8.74e-06 | 44 | 21 | 3 | CID000016547 | |
| Drug | CTFE | 1.00e-05 | 46 | 21 | 3 | CID000006594 | |
| Drug | ethyl-p-((E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-1-propenyl)benzoic acid | 1.21e-05 | 6 | 21 | 2 | ctd:C034814 | |
| Drug | ClOClO | 1.21e-05 | 6 | 21 | 2 | CID000517862 | |
| Drug | NSC134723 | 1.21e-05 | 6 | 21 | 2 | CID000281830 | |
| Drug | ClOO | 1.70e-05 | 7 | 21 | 2 | CID005460593 | |
| Drug | phenyl saligenin phosphate | 1.82e-05 | 56 | 21 | 3 | CID000104885 | |
| Drug | cignolin | 1.82e-05 | 56 | 21 | 3 | CID000010187 | |
| Drug | AC1N9J6O | 2.13e-05 | 182 | 21 | 4 | CID004411483 | |
| Drug | methyl carbonate | 2.26e-05 | 8 | 21 | 2 | CID000012021 | |
| Drug | CD437 | 3.26e-05 | 203 | 21 | 4 | CID000135411 | |
| Drug | ClOOCl | 3.63e-05 | 10 | 21 | 2 | CID000123287 | |
| Drug | 9-cis-acitretin | 3.71e-05 | 71 | 21 | 3 | CID000041317 | |
| Drug | 4-oxoretinoic acid | 4.73e-05 | 77 | 21 | 3 | CID006437063 | |
| Drug | triphenyltin | 6.28e-05 | 13 | 21 | 2 | CID005357402 | |
| Drug | Isotretinoin | 6.33e-05 | 799 | 21 | 6 | ctd:D015474 | |
| Drug | altanserin | 8.45e-05 | 15 | 21 | 2 | CID003033676 | |
| Drug | terpy | 8.45e-05 | 15 | 21 | 2 | CID000070848 | |
| Drug | 3-deoxy-3-fluoro-D-glucose | 8.45e-05 | 15 | 21 | 2 | CID000450201 | |
| Drug | potassiopotassium | 8.59e-05 | 94 | 21 | 3 | CID006432276 | |
| Drug | NS-398 | 9.05e-05 | 264 | 21 | 4 | CID000004553 | |
| Drug | 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid | 9.65e-05 | 16 | 21 | 2 | ctd:D019377 | |
| Drug | AC1O517G | 9.65e-05 | 16 | 21 | 2 | CID006450188 | |
| Drug | bilirubin-phosphate | 9.65e-05 | 16 | 21 | 2 | CID005497144 | |
| Drug | K-12 | 1.09e-04 | 17 | 21 | 2 | CID000469668 | |
| Drug | Diethylstilbestrol | 1.14e-04 | 1305 | 21 | 7 | ctd:D004054 | |
| Drug | 2c5o | 1.20e-04 | 284 | 21 | 4 | CID000447956 | |
| Drug | JTV-519 | 1.23e-04 | 18 | 21 | 2 | CID000001715 | |
| Drug | Mustard Gas | 1.35e-04 | 1341 | 21 | 7 | ctd:D009151 | |
| Drug | AC1L9LFK | 1.37e-04 | 19 | 21 | 2 | CID000447957 | |
| Drug | K 10 | 1.37e-04 | 19 | 21 | 2 | CID000221089 | |
| Drug | alitretinoin | 1.50e-04 | 301 | 21 | 4 | ctd:C103303 | |
| Drug | AC1NPJ0T | 1.52e-04 | 20 | 21 | 2 | CID005159168 | |
| Drug | dichloromethyl | 1.52e-04 | 20 | 21 | 2 | CID000123193 | |
| Drug | Lh 1 | 1.85e-04 | 22 | 21 | 2 | CID000191841 | |
| Drug | Arsenates | 1.86e-04 | 122 | 21 | 3 | ctd:D001149 | |
| Drug | EMD 57033 | 2.03e-04 | 23 | 21 | 2 | CID000187079 | |
| Drug | N-nitrosomorpholine | 2.34e-04 | 338 | 21 | 4 | ctd:C002741 | |
| Drug | AC1L9H5I | 2.80e-04 | 27 | 21 | 2 | CID000444945 | |
| Drug | CH2Cl | 3.02e-04 | 28 | 21 | 2 | CID005378701 | |
| Drug | 15-hydroxy-5,8,11,13-eicosatetraenoic acid | 3.02e-04 | 28 | 21 | 2 | ctd:C025984 | |
| Drug | T0070907 | 3.71e-04 | 31 | 21 | 2 | CID002777391 | |
| Drug | GW0742 | 3.71e-04 | 31 | 21 | 2 | ctd:C479979 | |
| Drug | AC1NBTRA | 3.95e-04 | 32 | 21 | 2 | CID004473609 | |
| Drug | AC1L1H88 | 3.95e-04 | 32 | 21 | 2 | CID000004018 | |
| Drug | mantATP | 4.73e-04 | 35 | 21 | 2 | CID000123756 | |
| Drug | tobacco tar | 5.27e-04 | 174 | 21 | 3 | ctd:C024746 | |
| Drug | chrysarobin | 5.29e-04 | 37 | 21 | 2 | CID000068111 | |
| Drug | sodium chromate(VI) | 5.29e-04 | 37 | 21 | 2 | ctd:C028982 | |
| Drug | liarozole | 5.88e-04 | 39 | 21 | 2 | CID000060652 | |
| Drug | tazarotene | 6.19e-04 | 40 | 21 | 2 | CID000005381 | |
| Drug | Securinine [5610-40-2]; Up 200; 18.4uM; HL60; HT_HG-U133A | 6.71e-04 | 189 | 21 | 3 | 2729_UP | |
| Drug | Roxarsone | 6.82e-04 | 42 | 21 | 2 | ctd:D012406 | |
| Drug | NSC759576 | 6.91e-04 | 191 | 21 | 3 | CID000003075 | |
| Drug | rosiglitazone maleate; Down 200; 10uM; PC3; HG-U133A | 7.23e-04 | 194 | 21 | 3 | 430_DN | |
| Drug | Glipizide [29094-61-9]; Up 200; 9uM; MCF7; HT_HG-U133A | 7.34e-04 | 195 | 21 | 3 | 4991_UP | |
| Drug | Butylparaben [94-26-8]; Up 200; 20.6uM; MCF7; HT_HG-U133A | 7.34e-04 | 195 | 21 | 3 | 5608_UP | |
| Drug | Torsemide [56211-40-6]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 7.45e-04 | 196 | 21 | 3 | 3517_UP | |
| Drug | Aminohippuric acid [61-78-9]; Up 200; 20.6uM; MCF7; HT_HG-U133A | 7.45e-04 | 196 | 21 | 3 | 6453_UP | |
| Drug | Amphotericin B [1397-89-3]; Up 200; 4.4uM; HL60; HT_HG-U133A | 7.45e-04 | 196 | 21 | 3 | 2441_UP | |
| Drug | A805480 | 7.49e-04 | 44 | 21 | 2 | CID000620368 | |
| Drug | ganglioside GD2 | 7.49e-04 | 44 | 21 | 2 | CID006450346 | |
| Drug | N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester | 7.49e-04 | 44 | 21 | 2 | ctd:C419410 | |
| Drug | Delsoline [509-18-2]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 7.56e-04 | 197 | 21 | 3 | 7212_UP | |
| Drug | Carbinoxamine maleate salt [3505-38-2]; Up 200; 9.8uM; PC3; HT_HG-U133A | 7.56e-04 | 197 | 21 | 3 | 7138_UP | |
| Disease | Keratoderma, Palmoplantar | 1.73e-07 | 16 | 21 | 3 | C4551675 | |
| Disease | Epidermolytic ichthyosis | 4.82e-07 | 2 | 21 | 2 | cv:C0079153 | |
| Disease | Erythrokeratoderma, Reticular | 4.82e-07 | 2 | 21 | 2 | C1836681 | |
| Disease | Annular epidermolytic ichthyosis | 4.82e-07 | 2 | 21 | 2 | cv:C1843463 | |
| Disease | Congenital reticular ichthyosiform erythroderma | 4.82e-07 | 2 | 21 | 2 | C3665704 | |
| Disease | Keratosis of Greither | 4.82e-07 | 2 | 21 | 2 | C2936837 | |
| Disease | Ichthyosis, Cyclic, with Epidermolytic Hyperkeratosis | 4.82e-07 | 2 | 21 | 2 | C1843463 | |
| Disease | epidermolytic hyperkeratosis (is_implicated_in) | 4.82e-07 | 2 | 21 | 2 | DOID:4603 (is_implicated_in) | |
| Disease | cinnamaldehyde measurement | 4.82e-07 | 2 | 21 | 2 | EFO_0021839 | |
| Disease | Palmoplantar keratoderma, epidermolytic | 4.82e-07 | 2 | 21 | 2 | cv:C1721006 | |
| Disease | Keratoderma, Palmoplantar, Epidermolytic | 1.45e-06 | 3 | 21 | 2 | C1721006 | |
| Disease | Epidermolytic palmoplantar keratoderma Vorner type | 1.45e-06 | 3 | 21 | 2 | C2931735 | |
| Disease | epidermolytic hyperkeratosis (implicated_via_orthology) | 1.45e-06 | 3 | 21 | 2 | DOID:4603 (implicated_via_orthology) | |
| Disease | Epidermolytic palmoplantar keratoderma of Vorner | 1.45e-06 | 3 | 21 | 2 | C0343110 | |
| Disease | Hyperkeratosis, Epidermolytic | 4.82e-06 | 5 | 21 | 2 | C0079153 | |
| Disease | Skin Neoplasms | 9.84e-06 | 59 | 21 | 3 | C0037286 | |
| Disease | Malignant neoplasm of skin | 9.84e-06 | 59 | 21 | 3 | C0007114 | |
| Disease | Squamous cell carcinoma | 9.12e-05 | 124 | 21 | 3 | C0007137 | |
| Disease | Neoplastic Cell Transformation | 1.28e-04 | 139 | 21 | 3 | C0007621 | |
| Disease | differentiated thyroid carcinoma | 2.83e-04 | 35 | 21 | 2 | EFO_1002017 | |
| Disease | Malignant neoplasm of salivary gland | 4.69e-04 | 45 | 21 | 2 | C0220636 | |
| Disease | Breast Carcinoma | 5.11e-04 | 538 | 21 | 4 | C0678222 | |
| Disease | Salivary Gland Neoplasms | 5.12e-04 | 47 | 21 | 2 | C0036095 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GGGGGGAGAGGAGAG | 406 | Q8NFD5 | |
| AGAGAGGGGGGGGAG | 96 | Q16676 | |
| SFGGGGFGGGGFGGG | 116 | P13645 | |
| GFGGGGFGGGFGGGF | 121 | P13645 | |
| GFGGGFGGGFGGDGG | 126 | P13645 | |
| GGGGGGGGAAGAGGA | 231 | O75444 | |
| FGGGFGGGSGGGFGG | 111 | P35527 | |
| HGGGGGGFGGGGFGS | 46 | P35908 | |
| GGGFGGGRGMGGGFG | 106 | P12035 | |
| GGGFGGAGGFGGAGG | 116 | P12035 | |
| GAGGFGGAGGFGGAG | 121 | P12035 | |
| GFGGGAGGGFGLGGG | 106 | P13647 | |
| AAGGGGDGGGGGGGA | 11 | O43525 | |
| GGYGGGLGGGFGGGF | 71 | P13646 | |
| GGGYGGGGFGGGGFG | 91 | P04264 | |
| GGGFGGGGFGGGGFG | 96 | P04264 | |
| GGGFGGGGFGGGGIG | 101 | P04264 | |
| GGGFGGGGIGGGGFG | 106 | P04264 | |
| GGGIGGGGFGGFGSG | 111 | P04264 | |
| GGGFGGFGSGGGGFG | 116 | P04264 | |
| GFGSGGGGFGGGGFG | 121 | P04264 | |
| GGGFGGGGFGGGGYG | 126 | P04264 | |
| GGGGGGGGRGGGGFH | 51 | P22087 | |
| FPGGAGGGGGGGGGG | 126 | P28356 | |
| GGGSGGGGCGFFGGG | 26 | P23490 | |
| GGGCGFFGGGGSGGG | 31 | P23490 | |
| FGGGVGGGFGGGFGG | 81 | P19012 | |
| GGGFGGGFGGGDGGL | 86 | P19012 | |
| FGGAAGGAGGGGGGG | 336 | Q8WXS5 | |
| GGGGAGAAGGGGGGE | 76 | P14866 | |
| GGGGGGGGGNFRGGG | 31 | Q9NY12 | |
| GNGAGGGGAGGAGGG | 51 | O95343 | |
| GAGGGGGGFGGGGGF | 66 | O43516 | |
| GGGFGGGGGFGGGGG | 71 | O43516 | |
| GAGGGGMFGSGGGGG | 381 | P19838 |